September 21, 2020
The North Carolina Partnerships to Increase Colorectal Cancer Screening (NC PICCS) will use the five-year grant to increase colorectal cancer screening and provide follow-up services for program-eligible people.
August 31, 2020
July 20, 2020
July 20, 2020
April 6, 2020
Since her cancer diagnosis, Caterri Woodrum left an executive position in the arts and now focuses on health care and health coaching to help others.
November 14, 2019
The North Carolina Cancer Hospital, the clinical home of UNC Lineberger Comprehensive Cancer Center, has named the multidisciplinary clinic reception area in honor of Karen Isner, a two-time cancer survivor and the mother of professional tennis player John Isner.
March 19, 2019
Next-generation sequencing of tumor DNA from patients with colorectal cancer revealed genetic alterations that were linked to different survival and treatment outcomes in an analysis led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher. The findings, published in the Journal of Clinical Oncology, could help define strategies to more effectively treat colorectal …
October 15, 2015
UNC Lineberger Comprehensive Cancer Center researchers are working to better understand the cell-to-cell signaling that can cause precancerous polyps in the colon when signaling goes awry. In a study published in the open-access journal eLife, they describe the role of a key tumor suppressor protein called APC in helping to keep cells in the colon crypts from growing out of control.
August 25, 2015
In the population-based, case study published Monday in the Annals of Internal Medicine, researchers led by Danish scientists honed in on the patterns of use of aspirin and NSAIDs needed for protection from colorectal cancer.
June 26, 2015
In a study published in Nature Medicine, UNC Lineberger Comprehensive Cancer Center researchers report their findings of just how a certain tumor-suppressing protein helps prevent colon cancer. With this discovery, the researchers believe they’ve found a possible drug target for colon cancer patients who lack the tumor suppressor.
